These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1084903)

  • 1. Cellular specificity of plasmacytoma-induced immunosuppression.
    Zolla-Pazner S; Sullivan B; Richardson D
    J Immunol; 1976 Aug; 117(2):563-8. PubMed ID: 1084903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the humoral immune response by plasmacytomas: mediation by adherent mononuclear cells.
    Kolb JP; Arrian S; Zolla-Pazner S
    J Immunol; 1977 Feb; 118(2):702-9. PubMed ID: 138708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression in a murine B cell leukemia (BCL1): role of an adherent cell in the suppression of primary in vitro antibody responses.
    Anderson SA; Isakson PC; Puré E; Muirhead M; Uhr JW; Vitetta ES
    J Immunol; 1981 Apr; 126(4):1603-7. PubMed ID: 6451649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocompetence status as related to growth progression of mouse MOPC-315 plasmacytoma.
    Rashid G; Ophir R; Pecht M; Ben-Efraim S
    In Vivo; 1989; 3(4):279-84. PubMed ID: 2535271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo.
    Röllinghoff M; Wagner H
    Eur J Immunol; 1973 Aug; 3(8):471-6. PubMed ID: 4543174
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and characterization of in vitro and in vivo functions of a tumor-specific T suppressor cell clone from a BALB/c mouse bearing the syngeneic ADJ-PC-5 plasmacytoma.
    Haubeck HD; Kölsch E
    J Immunol; 1985 Dec; 135(6):4297-302. PubMed ID: 2415609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice.
    Patel M; Havas HF
    Immunology; 1982 May; 46(1):97-105. PubMed ID: 6978846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary in vitro lymphocyte-proliferative responses to syngeneic plasma cell tumors.
    Boyer PJ; Fahey JL
    Cancer Res; 1976 Apr; 36(4):1492-8. PubMed ID: 1083290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of splenectomy on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).
    Havas HF; Berney S; Goodis A; Schiffman G
    Cancer Res; 1979 Sep; 39(9):3783-7. PubMed ID: 476702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular changes and antitumor responses in the plasmacytoma-bearing mouse following cyclophosphamide treatment.
    Shanahan TC; Ceglowski WS; Havas HF
    Cancer Res; 1985 Dec; 45(12 Pt 1):6463-70. PubMed ID: 2866030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological reactivity to a mycobacterial fraction is associated with nonspecific suppression of immunological responsiveness in vivo.
    Halperin D; Reuben C; Rashid G; Ben-Efraim S; Weiss DW
    In Vivo; 1990; 4(4):263-8. PubMed ID: 2103371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of self-cure from Trypanosoma congolense infection in mice.
    Pinder M; Chassin P; Fumoux F
    J Immunol; 1986 Feb; 136(4):1427-34. PubMed ID: 3484768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population.
    von der Weid T; Beebe AM; Roopenian DC; Coffman RL
    J Immunol; 1996 Nov; 157(10):4421-7. PubMed ID: 8906817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloma-induced immunosuppression: a multistep mechanism.
    Katzmann JA
    J Immunol; 1978 Oct; 121(4):1405-9. PubMed ID: 701801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary and secondary immune response induced in vitro against syngeneic murine plasma cell tumors.
    Röllinghoff M; Wagner H
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:304. PubMed ID: 4546887
    [No Abstract]   [Full Text] [Related]  

  • 18. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
    Marsili MA; Walker MC; Phillips-Quagliata JM
    Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of suppressed cell-mediated immunity and impaired antigen-induced interleukin 2 production in granuloma-bearing mice.
    Kobayashi K; Allred C; Yoshida T
    J Immunol; 1985 Nov; 135(5):2996-3003. PubMed ID: 2931477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective loss of suppressor cell function in New Zealand mice induced by NTA.
    Klassen LW; Krakauer RS; Steinberg AD
    J Immunol; 1977 Sep; 119(3):830. PubMed ID: 19534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.